A steam inhaler includes a steam chamber housing having mounted therein a heater assembly. The steam chamber housing defines a steam chamber adapted to receive water. A fitting mounted to the steam chamber housing has a steam conduit section extended toward an exterior vent opening, a nozzle conduit section extended from the steam conduit, and a fresh air conduit section extended from the steam conduit section at a location downstream of the nozzle conduit section. The fitting is configured such that steam flows freely from the steam chamber, through the steam conduit section toward the exterior vent opening, a suction provided at the nozzle redirects at least a portion of the steam into the nozzle conduit section toward a mask, and the fresh air conduit directs fresh air into the steam conduit section to reduce a temperature of the steam exiting the exterior vent opening.

A closed-loop artificial pancreas controlled by body movements, which includes: a sensor used for detecting blood glucose concentration; an infusion module used for infusing drug into the body; a control module connected to the sensor and the infusion module, respectively; and a sensing module operatively connected to the control module and used to sense or recognize the user's body movements, and different body movements represent different functional instructions, and according to the body movement sensed or recognized by the sensing module, the control module controls the sensor or the infusion module to execute corresponding functional instructions, which enhances the user experience.

A method for determining that a patient interface component comprising a vent has been replaced between therapy sessions of treatment of sleep disordered breathing, the method comprising: acquiring or receiving first vent flow rate data representing one or more estimated first vent flow rates of gas through a first vent of a patient interface in use during a first therapy session; acquiring or receiving second vent flow rate data representing one or more estimated second vent flow rates of gas through a second vent of a patient interface in use during a second therapy session after the first therapy session; and identifying, by comparison of the second vent flow rate data to the first vent flow rate data, a difference in resistance to flow through the first vent than through the second vent indicating that the second vent is not the same vent as the first vent.

The invention relates to the field of inhalation devices for liquids. In particular, the invention relates to an inhalation device having improved flow characteristics. A inhalation device for medically active liquids (F) for generation of an aerosol comprises a housing (1), inside this housing (1) a reservoir (2) for storing a liquid (F), a pumping device with a hollow cylinder (9) providing a pumping chamber (3) for the generation of a pressure inside said pumping chamber (3), wherein the pumping chamber is fluidically connected with the reservoir (2) via an inlet check valve (4) which blocks in direction of the reservoir (2), a riser pipe (5) which can be received with at least one reservoir-facing, interior end (5A) in said hollow cylinder (9), and a nozzle (6) which is connected liquid-tight to an exterior end (5B) of the riser pipe (5), wherein the volume of the pumping chamber (3) is changeable by means of relative motion of the cylinder (9) to the riser pipe (5), and is characterised in that the riser pipe (5) is immobile and firmly attached to the housing (1) and to the nozzle (6), whereas the hollow cylinder (9) is moveable relative to the housing (1) and to the nozzle (6). The invention also discloses a method for the generation of an aerosol of a medically active liquid (F) by means of an inhalation device.

An inhalation-synchronized fluid product dispenser device having a body (10) provided with a mouthpiece (400), a product reservoir (100) containing fluid product, and a dispenser mechanism (200). The device has a blocking mechanism (500; 600) for the dispenser mechanism and an inhalation-controlled trigger system having an inhalation-sensitive member (60) deformable and/or movable by inhalation, the inhalation-sensitive member co-operating with the blocking mechanism so that when deformed and/or moved, it enables the dispenser mechanism to be actuated. The device has a protective element (1) the trigger system, the protective element disposed between the mouthpiece and the inhalation-sensitive member and made of a porous material that allows air to pass through it but blocks the passage of water, dust and foreign bodies.

An ejection-type safety intravenous needle includes a sheath, a hub, a cannula fixed on the hub, and a base. An accommodation cavity is formed in the base. The hub is fixed in the accommodation cavity, and the cannula is exposed outside of the accommodation cavity. The sheath encloses the cannula, and a bottom of the sheath is located in the accommodation cavity and provided with a first limiting structure. A second limiting structure cooperating with the first limiting structure is provided at a top of the accommodation cavity. An elastic element is provided in the accommodation cavity, and the elastic element abuts against a bottom end of the sheath. A top and a bottom of the base are provided with a first clamping structure and a second clamping structure, respectively. A third clamping structure cooperating with the first clamping structure and the second clamping structure is provided on the sheath.

A opioid overdose treatment assembly for treating an opioid overdose includes a housing that can be worn on a user. An inhaler is coupled to the housing and the inhaler contains an aerosolized medication for treating an opioid overdose. The inhaler is actuatable to release a pre-determined amount of the aerosolized medication for inhalation by the user when the user is suffering from an opioid overdose. A communicator is coupled to the housing and the communicator is in wireless communication with a communication network. In this way the communicator can be placed in communication with emergency responders.

Provided herein are the safety features for radiopharmaceutical infusion system for treatment or diagnostic purpose, wherein infusion system comprises a controller, a source of radiopharmaceutical including other components. The controller is configured to perform automated quality control steps at the start of the system during daily quality control and ensure that system complies to desired technical attributes prior to administration to patients. The quality control steps comprise calibration, breakthrough testing, checking for unauthorized connection and/or malware in the system, network or other connected devices.

An inhalation device uses a base substance to generate aerosol to be inhaled by a user. The inhalation device includes a storage unit that stores information, a communication unit that receives information from another device when a first condition is satisfied, and a control unit that causes the storage unit to store the information received from the other device when a second condition is satisfied.

The present technology relates to a headgear for a patient interface, comprising one or more straps each having a first end for connecting to a mask. The first end of each strap comprises a connection portion which is grippable by a user to pull the strap to increase a tension in the strap, a first rigid member and a second rigid member that extends from a resilient carrier that is connected to the connection portion. The second rigid member is movable relative to the first rigid member when the connection portion is pulled. At least part of the second rigid member is arranged to strike the first rigid member to cause at least an audible alert when the second rigid member travels further than a threshold distance. The resilient carrier is constructed and arranged such that the threshold distance corresponds to a desired tension limit for the strap.